Literature DB >> 30604463

Effective treatment and decolonization of a dog infected with carbapenemase (VIM-2)-producing Pseudomonas aeruginosa using probiotic and photodynamic therapies.

Fábio P Sellera1, Miriam R Fernandes2, Caetano P Sabino2,3, Laura M de Freitas4, Luciano C B A da Silva5, Fabio C Pogliani1, Martha S Ribeiro6, Michael R Hamblin7,8, Nilton Lincopan2,9.   

Abstract

BACKGROUND: Carbapenem-resistant bacterial infections are a critical problem in veterinary medicine with limited treatment options.
OBJECTIVE: To describe effective probiotic and photodynamic therapy of a dog with gut colonization and ear infection caused by a hospital-associated lineage of carbapenemase (VIM-2)-producing Pseudomonas aeruginosa. ANIMALS: A 5-year-old Lhasa apso dog presented with otitis externa. METHODS AND MATERIALS: Unilateral otitis externa caused by carbapenem-resistant P. aeruginosa was treated with antimicrobial photodynamic therapy (aPDT) using methylene blue as photosensitizer [wavelength 660 nm, fluence 140 J/cm2 , 8 J and 80 s per point (six equidistant points), 100 mW, spot size 0.028 cm2 and fluence rate 3.5 W/cm2 ]. The isolated bacterial strain also was tested for susceptibility to in vitro aPDT where the survival fraction was quantified by colony forming unit counts after exposure to increasing light doses. For decolonization, probiotic supplements were orally administered (once daily) for 14 days. Effectiveness of probiotics and photodynamic therapy was evaluated by clinical and microbiological culture assays.
RESULTS: Complete resolution of clinical signs was achieved by Day 7 after aPDT. Samples collected immediately and after seven and 14 days following aPDT were negative for VIM-2-producing P. aeruginosa. Oral and rectal swabs collected on days 7, 14 and 21 after probiotic therapy, confirmed effective gastrointestinal decolonization. CONCLUSIONS AND CLINICAL IMPORTANCE: Combined use of aPDT and probiotics could be a promising therapeutic strategy for treatment of superficial infections produced by carbapenem-resistant bacteria, while avoiding recurrent infection due to intestinal bacterial carriage of these multidrug-resistant pathogens.
© 2019 ESVD and ACVD.

Entities:  

Year:  2019        PMID: 30604463      PMCID: PMC6610805          DOI: 10.1111/vde.12714

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  11 in total

1.  Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: a systematic review.

Authors:  R Köck; I Daniels-Haardt; K Becker; A Mellmann; A W Friedrich; D Mevius; S Schwarz; A Jurke
Journal:  Clin Microbiol Infect       Date:  2018-04-11       Impact factor: 8.067

2.  Identification of KPC-2-producing Escherichia coli in a companion animal: a new challenge for veterinary clinicians.

Authors:  Fábio P Sellera; Miriam R Fernandes; Regina Ruiz; Ana C M Falleiros; Fernanda P Rodrigues; Louise Cerdeira; Nilton Lincopan
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

3.  In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.

Authors:  Wei Yee Chan; Elizabeth E Hickey; Manouchehr Khazandi; Stephen W Page; Darren J Trott; Peter B Hill
Journal:  Vet Dermatol       Date:  2018-01-24       Impact factor: 1.589

4.  Identification of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.

Authors:  Jae-Eun Hyun; Tae-Ho Chung; Cheol-Yong Hwang
Journal:  Vet Dermatol       Date:  2018-03-25       Impact factor: 1.589

5.  Multidrug-resistant CTX-M-15-producing Klebsiella pneumoniae ST231 associated with infection and persistent colonization of dog.

Authors:  Meire M Silva; Miriam R Fernandes; Fábio P Sellera; Louise Cerdeira; Lylian K G Medeiros; Felício Garino; Sérgio S Azevedo; Nilton Lincopan
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-22       Impact factor: 2.803

Review 6.  Evidence-based veterinary dermatology: a systematic review of interventions for treatment of Pseudomonas otitis in dogs.

Authors:  Tim Nuttall; Lynette K Cole
Journal:  Vet Dermatol       Date:  2007-04       Impact factor: 1.589

Review 7.  Photoantimicrobials-are we afraid of the light?

Authors:  Mark Wainwright; Tim Maisch; Santi Nonell; Kristjan Plaetzer; Adelaide Almeida; George P Tegos; Michael R Hamblin
Journal:  Lancet Infect Dis       Date:  2016-11-22       Impact factor: 25.071

8.  Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.

Authors:  Claire L Gorrie; Mirjana Mirceta; Ryan R Wick; David J Edwards; Nicholas R Thomson; Richard A Strugnell; Nigel F Pratt; Jill S Garlick; Kerri M Watson; David V Pilcher; Steve A McGloughlin; Denis W Spelman; Adam W J Jenney; Kathryn E Holt
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

9.  Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity.

Authors:  Silvia I Cazorla; Carolina Maldonado-Galdeano; Ricardo Weill; Juan De Paula; Gabriela D V Perdigón
Journal:  Front Microbiol       Date:  2018-04-16       Impact factor: 5.640

10.  Zooanthroponotic Transmission of Drug-Resistant Pseudomonas aeruginosa, Brazil.

Authors:  Miriam R Fernandes; Fábio P Sellera; Quézia Moura; Marcelo P N Carvalho; Paula N Rosato; Louise Cerdeira; Nilton Lincopan
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

View more
  3 in total

Review 1.  Oxygen-Independent Antimicrobial Photoinactivation: Type III Photochemical Mechanism?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Antibiotics (Basel)       Date:  2020-01-31

2.  Critically Appraised Topic on Low-Level Laser Therapy (LLLT) in Dogs: An Advisable Treatment for Skin Diseases?

Authors:  Roberta Perego; Martina Mazzeo; Eva Spada; Daniela Proverbio
Journal:  Vet Sci       Date:  2022-09-14

3.  Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?

Authors:  Fábio P Sellera; Caetano P Sabino; Silvia C Nuñez; Martha S Ribeiro
Journal:  Photodiagnosis Photodyn Ther       Date:  2022-10-13       Impact factor: 3.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.